Add time:09/01/2019         Source:sciencedirect.com

BackgroundLupin, the largest legume crop in Australia, is gaining global attention because of its unique protein γ-conglutin, which has shown promise as a nutraceutical for controlling blood glucose level and thus reducing the risk of type II diabetes development. Type II diabetes is a chronic condition affecting millions of individuals worldwide, which urgently requires natural side effect free therapies as alternatives to currently used drugs. Purification of γ-conglutin opens up a new avenue for high-value products from lupin seeds as nutraceuticals, the market for which is predicted to reach US$ 250 billion by 2018 (Dutta, Mahabir, & Pathak, 2013).

We also recommend Trading Suppliers and Manufacturers of conglutins (cas 1391-07-7). Pls Click Website Link as below: cas 1391-07-7 suppliers